Navigation Links
St Jude Retreats Reveals Addiction Treatment Industry Possess Healthy Revenue Stream
Date:12/6/2012

Amsterdam, NY (PRWEB) December 06, 2012

In a recent blog post, Acadia Healthcare Company paid $90 million for Timberline Knolls an inpatient treatment program in Chicago whose profit margins were "through the roof." The report notes that the addiction treatment industry is not only financially stable but a great investment. St Jude Retreats findings have concluded that individuals do not need treatment to overcome substance use as the non-treatment program has helped 62% of program graduates to stop or moderate their use and improve their overall quality of life. Findings additionally concluded individuals had a better chance of overcoming substance use problems if they had never been treated in their first place.

Foundations Recovery CEO Michael Cartwright believes addiction treatment is a good investment because "3.5 million people a year go to treatment, there have been no rate decreases and the average length of stay is consistent." However according to St Jude's sending someone to treatment is less successful than if they remain untreated.

"Teaching people they are suffering from a progressive, incurable disease is counterproductive to their success, but it ensures a steady stream of repeat customers. When someone relapses they are told they need more extensive treatment. It’s peculiar because this is the only industry where the solution for treatment’s lack of success is more of the exact same treatment," states Michelle Dunbar, Executive Director of St Jude Retreats.

According to Stanton Peele, In Addiction Proof Your Child, "It is startling to learn that the large majority of alcoholics are never treated and that the large majority of these recover anyhow."

Results from the 2011 National Survey on Drug Use and Health Summary of National Findings completed by SAMSHA revealed that illicit drug use by teens and adults significantly decreases as a function of age. The report shows Figure 2.5 in 2011 for those in the survey age 18-20 23.8% of individuals had used illicit drugs in the past month, whereas the age group 35-39 results in 8.2% of use. This study supports the conclusion that people naturally mature out of substance use as they advance in age, making alcohol or drug use a temporary stage of behavior.

Dunbar adds, “Drug treatment is a multibillion dollar business throughout the country. Keeping addiction a disease ensures millions in state and federal tax dollars as well as insurance dollars keep flowing into drug treatment programs, even when research has shown these programs lower an individual’s chances of overcoming their drug or alcohol problem.”

The St Jude Retreats is a non-disease, non-treatment based drug and alcohol program implementing proprietary methodology called Cognitive Behavioral EducationSM (CBE). The program is the only effective alternative to alcohol rehab and drug treatment centers and is currently 85% more effective than treatment. The program is endorsed by internationally acclaimed professionals and addiction research authors such as Prof. Emeritus David Hanson, PhD; Prof. David Rudy, PhD; Dr. Joy Browne and the late Joseph Vacca, PhD, among others.

Read the full story at http://www.prweb.com/releases/alcoholtreatment/StJudeRetreats/prweb10203904.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Research reveals new understanding of X chromosome inactivation
2. DNA packaging discovery reveals principles by which CRC mutations may cause cancer
3. Study reveals insights that could aid in therapeutic use of mesenchymal stem cells
4. Study Reveals Gender Gap in Spotting Depression
5. Open access initiative reveals drug hits for deadly neglected tropical diseases
6. Penn research reveals new aspect of platelet behavior in heart attacks: Clots can sense blood flow
7. Protein reveals diabetes risk many years in advance
8. Attention, parents: UC research reveals a secret about your medicine cabinet
9. Study reveals teenage patients attitude towards social media and privacy
10. A TECNALIA study reveals the loss of nanomaterials in surface treatments caused by water
11. Discovery of essential genes for drug-resistant bacteria reveals new, high-value drug targets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... ... 2017 , ... Most us are familiar with the sound of occasional popping ... Osteoarthritis Initiative shows that certain people who experience consistent joint popping, grating and ... doctors the opportunity to treat patients before the problem becomes pronounced, potentially hedging off ...
(Date:5/26/2017)... Boston, Massachsetts (PRWEB) , ... May 26, 2017 ... ... communities will gather at Boston CEO 2017 on May 30th and 31st at ... off-the-record networking forum for leading executives in the life sciences, offering exclusive access ...
(Date:5/26/2017)... ... 26, 2017 , ... Somnoware, a leading provider of digital ... its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device integration ... platform, initializing devices and importing studies are just one-click operations. This plugin streamlines ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... copper, antimicrobial, mesh back 24/7 task chair specifically designed for clinical areas. Genie ... are thrilled to partner with Cupron® to provide customers with a game changing ...
(Date:5/26/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... being discussed by President Donald Trump and the rest of the world. Donald Trump ... peace talks in the continuous battle between Israel and Palestine. The world’s eyes are ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, today announced it has earned a spot ... 2017" list. The Company was ranked among 500 U.S. ... Employers and Healthcare Equipment and Services. The ... on an anonymous, independent survey of over 30,000 employees ...
(Date:5/9/2017)... 2017  Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... Property Office has granted Oramed a patent titled, ... The patent covers Oramed,s invention of an oral ... an incretin hormone that stimulates the secretion of ...
(Date:5/8/2017)... NEW YORK , May 8, 2017 ... in the transition from fee for service reimbursement. Black ... April 2017. 1.       The Market for ... 77% of physician practices with 3 or ... Compliance Technology Solutions by Q4. "Given the magnitude of ...
Breaking Medicine Technology: